Immediate Impact
44 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
HER2-targeted therapies in cancer: a systematic review
2024 Standout
Works of Mojca Unk being referenced
[ 18 F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab
2020
Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mojca Unk | 114 | 132 | 23 | 65 | 14 | 187 | |
| A. Qin | 140 | 195 | 27 | 87 | 19 | 262 | |
| Miao Huang | 155 | 183 | 60 | 33 | 17 | 291 | |
| Laura Ginocchi | 66 | 115 | 46 | 27 | 16 | 177 | |
| Guzel Mukhametshina | 90 | 140 | 26 | 46 | 15 | 187 | |
| Roslyn Wallace | 92 | 143 | 27 | 93 | 14 | 213 | |
| Jean-Baptiste Paoli | 208 | 172 | 35 | 52 | 10 | 279 | |
| J. De Langen | 94 | 116 | 27 | 27 | 17 | 146 | |
| Luisa Piccin | 63 | 160 | 25 | 30 | 16 | 207 | |
| Dingwei Ye | 60 | 137 | 77 | 54 | 12 | 194 | |
| Lutz Jacobasch | 112 | 140 | 15 | 19 | 18 | 187 |
All Works
Login with ORCID to disown or claim papers
Loading papers...